SA-030

N/A

Report date: 2026/05/06 20:02:28
NME

Base Information

Drug NameSA-030
Drug Alias NameSA-030SA030
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionActivin receptor type-1C inhibitors
TargetsActivin receptor type-1C
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Siran Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Siran Biotech Co LtdGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A